Zobrazeno 1 - 10
of 18
pro vyhledávání: '"Victoria G. Atkinson"'
Autor:
Oliver John Kennedy, Michal Kicinski, Sara Valpione, Sara Gandini, Stefan Suciu, Christian U. Blank, Georgina V. Long, Victoria G. Atkinson, Stéphane Dalle, Andrew M. Haydon, Andrey Meshcheryakov, Adnan Khattak, Matteo S. Carlino, Shahneen Sandhu, James Larkin, Susana Puig, Paolo A. Ascierto, Piotr Rutkowski, Dirk Schadendorf, Marye Boers-Sonderen, Anna Maria Di Giacomo, Alfonsus J.M. van den Eertwegh, Jean-Jacques Grob, Ralf Gutzmer, Rahima Jamal, Alexander C.J. van Akkooi, Caroline Robert, Alexander M.M. Eggermont, Paul Lorigan, Mario Mandala
Publikováno v:
European Journal of Cancer.
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::5d76ea38d5272210700d8b7c6e66bf27
https://doi.org/10.1016/j.ejca.2023.04.016
https://doi.org/10.1016/j.ejca.2023.04.016
Autor:
Helmut Schaider, Clemens Krepler, Meenhard Herlyn, Nikolas K. Haass, Brian Gabrielli, Victoria G. Atkinson, Min Xiao, Divya Thakkar, Katrin Sproesser, Joachim Torrano, Abdullah Al Emran, Sabrina Hammerlindl, Dinoop Ravindran Menon, Heinz Hammerlindl
Purpose: Identify and characterize novel combinations of sorafenib with anti-inflammatory painkillers to target difficult-to-treat RAS-mutant cancer.Experimental Design: The cytotoxicity of acetylsalicylic acid (aspirin) in combination with the multi
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::1b4169480db508d4656dfd01646de1f7
https://doi.org/10.1158/1078-0432.c.6525839
https://doi.org/10.1158/1078-0432.c.6525839
Autor:
Helmut Schaider, Clemens Krepler, Meenhard Herlyn, Nikolas K. Haass, Brian Gabrielli, Victoria G. Atkinson, Min Xiao, Divya Thakkar, Katrin Sproesser, Joachim Torrano, Abdullah Al Emran, Sabrina Hammerlindl, Dinoop Ravindran Menon, Heinz Hammerlindl
Supplementary Figure 1, Sorafenib in combination with aspirin but not COX1/2 inhibitors synergistically induces cell death in RAS or RAF mutant cancer cell lines. Supplementary Figure 2, the combination of sorafenib/aspirin activates ERK and AMPK sig
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::5b1bf64b398d54ccbb0954660b5b13f7
https://doi.org/10.1158/1078-0432.22464869.v1
https://doi.org/10.1158/1078-0432.22464869.v1
Autor:
Oliver J. Kennedy, Michal Kicinski, Sara Valpione, Sara Gandini, Stefan Suciu, Christian U. Blank, Georgina V. Long, Victoria G. Atkinson, Stéphane Dalle, Andrew M. Haydon, Andrey Meshcheryakov, Adnan Khattak, Matteo S. Carlino, Shahneen Sandhu, James Larkin, Susana Puig, Paolo A. Ascierto, Piotr Rutkowski, Dirk Schadendorf, Rutger Koornstra, Leonel Hernandez-Aya, Anna M. Di Giacomo, Alfonsus J.M. van den Eertwegh, Jean-Jacques Grob, Ralf Gutzmer, Rahima Jamal, Alexander C.J. van Akkooi, Caroline Robert, Alexander M.M. Eggermont, Paul Lorigan, Mario Mandala
Publikováno v:
European Journal of Cancer, 165, 97-112
European Journal of Cancer, 165, pp. 97-112
Kennedy, O J, Kicinski, M, Valpione, S, Gandini, S, Suciu, S, Blank, C U, Long, G V, Atkinson, V G, Dalle, S, Haydon, A M, Meshcheryakov, A, Khattak, A, Carlino, M S, Sandhu, S, Larkin, J, Puig, S, Ascierto, P A, Rutkowski, P, Schadendorf, D, Koornstra, R, Hernandez-Aya, L, Di Giacomo, A M, van den Eertwegh, A J M, Grob, J J, Gutzmer, R, Jamal, R, van Akkooi, A C J, Robert, C, Eggermont, A M M, Lorigan, P & Mandala, M 2022, ' Prognostic and predictive value of β-blockers in the EORTC 1325/KEYNOTE-054 phase III trial of pembrolizumab versus placebo in resected high-risk stage III melanoma ', European Journal of Cancer, vol. 165, pp. 97-112 . https://doi.org/10.1016/j.ejca.2022.01.017
European Journal of Cancer, 165, pp. 97-112
Kennedy, O J, Kicinski, M, Valpione, S, Gandini, S, Suciu, S, Blank, C U, Long, G V, Atkinson, V G, Dalle, S, Haydon, A M, Meshcheryakov, A, Khattak, A, Carlino, M S, Sandhu, S, Larkin, J, Puig, S, Ascierto, P A, Rutkowski, P, Schadendorf, D, Koornstra, R, Hernandez-Aya, L, Di Giacomo, A M, van den Eertwegh, A J M, Grob, J J, Gutzmer, R, Jamal, R, van Akkooi, A C J, Robert, C, Eggermont, A M M, Lorigan, P & Mandala, M 2022, ' Prognostic and predictive value of β-blockers in the EORTC 1325/KEYNOTE-054 phase III trial of pembrolizumab versus placebo in resected high-risk stage III melanoma ', European Journal of Cancer, vol. 165, pp. 97-112 . https://doi.org/10.1016/j.ejca.2022.01.017
Background: β-adrenergic receptors are upregulated in melanoma cells and contribute to an immunosuppressive, pro-tumorigenic microenvironment. This study investigated the prognostic and predictive value of β-adrenoreceptor blockade by β-blockers i
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::d75ba607dbd7225632c8df9aab98b7d3
http://hdl.handle.net/2066/250190
http://hdl.handle.net/2066/250190
Autor:
Alexander M, Menzies, Victoria G, Atkinson, Michael P, Brown, Matteo S, Carlino, Jonathan, Cebon, Alexander, Guminski, Richard F, Kefford, Georgina V, Long, Grant, McArthur, Catriona M, McNeil, Michael, Millward, Shahneen, Sandhu
Publikováno v:
Australian family physician. 44(12)
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::dfd64c38e1da24cf7fd255458a1d5377
https://pubmed.ncbi.nlm.nih.gov/26510152
https://pubmed.ncbi.nlm.nih.gov/26510152
Autor:
Mason, Robert1 (AUTHOR) robert.mason@health.qld.gov.au, Dearden, Helen C.2 (AUTHOR), Nguyen, Bella3 (AUTHOR), Soon, Jennifer A.4 (AUTHOR), Smith, Jessica Louise5 (AUTHOR), Randhawa, Manreet6 (AUTHOR), Mant, Andrew7 (AUTHOR), Warburton, Lydai3 (AUTHOR), Lo, Serigne2,8 (AUTHOR), Meniawy, Tarek3,9,10 (AUTHOR), Guminski, Alexander2,11 (AUTHOR), Parente, Phillip7,12 (AUTHOR), Ali, Sayed6,10 (AUTHOR), Haydon, Andrew4 (AUTHOR), Long, Georgina V.2,11 (AUTHOR), Carlino, Matteo S.2,5 (AUTHOR), Millward, Michael3,10 (AUTHOR), Atkinson, Victoria G.1,13,14 (AUTHOR), Menzies, Alexander M.2,11 (AUTHOR)
Publikováno v:
Pigment Cell & Melanoma Research. Mar2020, Vol. 33 Issue 2, p358-365. 8p.
Autor:
Pires da Silva, Ines1 (AUTHOR), Glitza, Isabella C.2 (AUTHOR), Haydu, Lauren E.2 (AUTHOR), Johnpulle, Romany3 (AUTHOR), Banks, Patricia D.4 (AUTHOR), Grass, George D.5 (AUTHOR), Goldinger, Simone M. A.6 (AUTHOR), Smith, Jessica L.7 (AUTHOR), Everett, Ashlyn S.8 (AUTHOR), Koelblinger, Peter9 (AUTHOR), Roberts‐Thomson, Rachel10 (AUTHOR), Millward, Michael11,12 (AUTHOR), Atkinson, Victoria G.13 (AUTHOR), Guminski, Alexander1,14 (AUTHOR), Kapoor, Rony1 (AUTHOR), Conry, Robert M.8 (AUTHOR), Carlino, Matteo S.1,7 (AUTHOR), Wang, Wei1,7 (AUTHOR), Shackleton, Mark J.4,15,16 (AUTHOR), Eroglu, Zeynep5 (AUTHOR)
Publikováno v:
Pigment Cell & Melanoma Research. Jul2019, Vol. 32 Issue 4, p553-563. 11p.
Autor:
Talley AC, Nicholas J
Publikováno v:
Medical Journal of Australia; Dec2019, Vol. 211 Issue 11, p484-489, 6p
Publikováno v:
Melanoma Research; Jun2019, Vol. 29 Issue 3, p333-337, 5p
Autor:
Atkinson, Victoria G.1 (AUTHOR) victoria.atkinson@health.qld.gov.au, Quaglino, Pietro2 (AUTHOR) pietro.quaglino@unito.it, Aglietta, Massimo3,4 (AUTHOR) massimo.aglietta@ircc.it, Del Vecchio, Michele5 (AUTHOR) Michele.DelVecchio@istitutotumori.mi.it, Depenni, Roberta6 (AUTHOR) depenni.roberta@policlinico.mo.it, Consoli, Francesca7 (AUTHOR) francesca.consoli@libero.it, Bafaloukos, Dimitrios8 (AUTHOR) dimmp@otenet.gr, Ferrucci, Pier Francesco9 (AUTHOR) pier.ferrucci@ieo.it, Tulyte, Skaiste10 (AUTHOR) skaiste.tulyte@santa.lt, Krajsová, Ivana11 (AUTHOR) ivana.krajsova@vfn.cz, Ascierto, Paolo A.12 (AUTHOR) paolo.ascierto@gmail.com, Gueli, Rossana13 (AUTHOR) rossana.gueli@asst-settelaghi.it, Arance, Ana14 (AUTHOR) amarance@clinic.cat, Gogas, Helen15 (AUTHOR) helgogas@gmail.com, Banerjee, Hiya16 (AUTHOR) hiya.banerjee@novartis.com, Saliba, Teddy16 (AUTHOR) teddy.saliba@novartis.com, de Jong, Egbert17 (AUTHOR) egbert.de_jong@novartis.com, Neyns, Bart18 (AUTHOR) Bart.Neyns@uzbrussel.be, Moulin, Alexandre (AUTHOR), Michielin, Olivier (AUTHOR)
Publikováno v:
Cancers. 5/15/2021, Vol. 13 Issue 10, p2466-2466. 1p.